The protocol is reviewed by clinicians, not copywriters.
Our scientific advisory group is responsible for the wavelength specification, dose curve, topical formulation, and the safety boundaries of the protocol. They are paid clinical consultants, not endorsers.
Clinical advisory team
Lead Dermatology Advisor
Board-certified dermatologist with academic faculty affiliation. Reviews member progress photos and protocol tuning quarterly.
Photobiomodulation Advisor
Researcher with published work on dermal red-light dosimetry. Owns the wavelength and irradiance specification.
Internal Medicine Advisor
Reviews safety boundaries — pregnancy, photosensitizing meds, and conditions where the protocol is not appropriate.
How the team is paid
Our advisors are paid hourly clinical consultants. They are not paid commission on sales, do not hold equity tied to revenue, and are free to publicly disagree with us. If we make a marketing claim that exceeds what the literature supports, an advisor can — and has — asked us to remove it.
Published literature the protocol is grounded in
- Avci et al., 2013 — Low-level laser therapy for skin: mechanism review.
- Wunsch & Matuschka, 2014 — Wavelength-controlled red-light study on collagen density.
- Barolet et al., 2009 — Light-emitting diode photomodulation: clinical use.
- Hamblin, 2016 — Mechanisms and applications of photobiomodulation.
Citations are linked from the science page. We will provide PDF copies on request to clinicians.
Clinician inquiry?
If you're a dermatologist, plastic surgeon, or aesthetic-medicine clinician interested in the device or topicals for clinic use, we have a clinic program with separate documentation.
Email clinic@dermosol.comRead the published research the protocol is built on
Every claim on this site cites peer-reviewed photobiomodulation literature.
Open the science page